Urinary tract infections and lupus erythematosus

Annals of the Rheumatic Diseases

Volumn 63, Issue 4, 2004, Pages 431-437

  Hidalgo Tenorio, C ^a   Jimenez Alonso J ^a   De Dios Luna, J ^a   Tallada, M ^a   Martinez Brocal A ^a   Sabio, J Mario ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HOSPITALIZATION; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; URINARY TRACT INFECTION;

ADULT; AGE FACTORS; ANTIBODIES, ANTINUCLEAR; ANTIRHEUMATIC AGENTS; ESCHERICHIA COLI; FEMALE; HOSPITALIZATION; HUMANS; LEUKOPENIA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; METHOTREXATE; PREVALENCE; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; THROMBOCYTOPENIA; URINARY TRACT INFECTIONS;

EID: 11144353881     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2003.006346     Document Type: Article

References (55)

1. Klippel JH. Systemic lupus erythematosus. Treatment-related complications superimposed on chronic disease. JAMA 1990;263:1812-15.
2. Abu-Shakra M, Mader R, Langevitz P, Friger M, Codish S, Neumann L, et al. Quality of life in systemic lupus erythematosus: a controlled study. J Rheumatol 1999;26:306-9.
3. Le Moing V, Leport C. Infections and Lupus. Rev Prat 1998;48:637-42.
4. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1999;78:167-75.
5. Rojas-Serrano J, Cardiel MH. Lupus patients in an emergency unit. Causes of consultation, hospitalization and outcome. A cohort study. Lupus 2000;9:601-6.
6. Nöel V, Lortholary O, Casassus P, Cohen P, Genéreau T, André MH, et al. Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis 2001;60:1141-4.
7. Petri M, Genovese M. Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of Hopkins lupus cohort. J Rheumatol 1992;19:1559-65.
8. Staples PJ, Gerding DN, Decker JL, Gordon RS. Incidence of infection in systemic lupus erythematosus. Arthritis Rheum 1974;17:1-11.
9. De Luis A, Pigrau C, Pahissa A, Fernández F, Martínez- Vazquez JM. Infections in 96 cases of systemic lupus erythematosus. Med Clin. (Barc). 1990;94:607-10.
10. Gómez J, Palazón D, Ortega G, Lucas E, Bru M, Campillo M, et al. Infections and systemic lupus erythematosus. Analysis of risk factors and prognosis. A prospective study (1979-1988). Rev Clin Esp 1991;188:72-5.
11. Uthman I, Soucy JP, Nicolet V, Senecal JL. Autosplenectomy in systemic lupus erythematosus. J Rheumatol 1996;23:1806-10.
12. Janwityanuchit S, Totemchokchyakarn K, Krachangwongchai K, Vatanasuk M. Infection in systemic lupus erythematosus. J Med Assoc Thai 1993;76:542-8.
13. Petri M. Infection in systemic lupus erythematosus. Rheum Dis Clin North Am 1998;24:423-56.
14. Duffy WKN, Duffy CM, Gladman DD. Infection and disease activity in systemic lupus erythematosus: a review of hospitalized patients. J Rheumatol 1991;18:1180-4.
15. Formiga Pérez F, Moga Sampere I, Canet González R, Pac Feraz M, Mitjavila Villero F, Fernández Nogues F. Infection and systemic lupus erythematosus: analysis of a series of 145 patients. Rev Clin Esp 1993;193:105-9.
16. Juega J, Pedreira JD, Adega M, Valdes F, Echaniz A. Infection in systemic lupus erythematosus. Rev Clin Esp 1989;184:245-6.
17. Nived O, Sturfelt G, Wollheim F. Systemic lupus erythematosus and infection: a controlled and prospective study including an epidemiological group. Q J Med 1985;55:217-87.
18. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
19. Hooton TM, Scholes D, Stapleton AE, Roberts PL, Winter C, Gupta K, et al. Prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med 2000;343:992-7.
20. Locke GR, Pemberton JH, Philips SF. American Gastroenterological Association medical position statement: guidelines on constipation. Gastroenterology 2000;119:1761-6.
21. Kunin CM. Urinary tract infections in females. Clin Infect Dis 1994;18:1-12.
22. Recommended terminology of urinary-tract infection. A report by the members of the Medical Research Council Bacteriuria Committee. Br Med J 1979;2:717-19.
23. Bloom DA, Foster WD, Mcleod DG, Mittemeyer BT, Stuzman RE. Cost-effective uroflowmerry in men. J Urol 1985;133:421-4.
24. Chancellor MB, Rivas DA, Mulholland SG, Drake WM. The invention of the modem uroflowmeter by Willard M. Drake, Jr at Jefferson Medical College. Urology 1998;51:671-5.
25. Dupont MC, Albo M, Raz S. Diagnosis of stress urinary incontinence. Urol Clin N Am 1996;23:407-15.
26. Bomardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, the Committee on Prognosis Studies in SLE. Derivation of trie SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
27. Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:809-13.
28. National Commite for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility test. 7th ed. Wayne, PA: NCCLS, 2000;20:document M2-A7.
29. Hooton TM. Patogenesis of urinary tract infections: an update. J Antimicrob Chemother 2000;46:1-7.
30. Lim E, Koh WH, Loh SF, Lam MS, Howe HS. Non-typhoidal Salmonellosis in patients with systemic lupus erythematosus. A study of fifty patients and review of the literature. Lupus 2001;10:87-92.
31. Hooton TM, Roberts PL, Stamm WE. Effects of recent sexual activity and use of a diaphragm on the vaginal microflora. Clin Infect Dis 1994;19:274-8.
32. Sobel JD. Pathogenesis of urinary tract infection. Infect Dis Clin North Am 1997;11:533-49.
33. Hooton TM, Scholes D, Huches JP, Winter C, Roberts PL, Stapelton AE, et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 1996;335:468-74.
34. Wagenlehner FM, Naber KG. Uncomplicated urinary tract infections in women. Curr Opin Urol 2001;11:49-53.
35. Van Haarst EP, Van Andel G, Heldeweg EA, Schlatmann TJ, Van Der Horst HJ. Evaluation of the diagnostic workup in young women referred for recurrent lower urinary tract infections. Urology 2001;57:1068-72.
36. Bjomsdottir LT, Geirsson RT, Jonsson PV. Urinary incontinence and urinary tract infections in octogenarian women. Acta Obstet Gynecol Scand 1998;77:105-9.
37. Eckford SD, Keane DP, Lamond E, Jackson SR, Abrams P. Hydration monitoring in the prevention of recurrent idiopothic urinary tract infections in pre-menopausal women. Br J Urol 1995;76:90-3.
38. Urowitz MB, Gladman DD. Eving spectrum of mortality and morbidity in SLE. Lupus 1999;8:253-5.
39. Ward MM, Pyun E, Studenski S. Causes of death in systemic lupus erythematosus. Arthritis Rheum 1995;38:1492-9.
40. Tishler M, Caspi D, Almog Y, Segal R, Yaron M. Increased incidence of urinary tract infection in patients with rheumatoid arthritis and secondary Sjögren's syndrome. Ann Rheum Dis 1992;51:604-6.
41. Jacobsen S, Petersen J, Ullman S, Junker P, Voss A, Rasmussen JM, et al. A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value. Clin Rheumtol 1998;17:478-84.
42. Koseda-Dragan M, Hebanowski M, Galinski J, Krzywinska E, Bakowska A. Asymptomatic bacteriuria in women diagnosed with systemic lupus erythematosus. Pol Arch Med Wewn 1998;100:321-30.
43. Pryor BD, Bologna SG, Kahl LE. Risk factors for serious infections during treatment with cyclophosphamide and corticosteroids for systemic lupus erythematosus. Arthritis Rheum 1996;39:1475-82.
44. Varela Aguilar JM, Sánchez Román J, Bravo Ferrer J. Severe infection in systemic lupus erythematosus. Rev Clin Esp 1990;186:97-8.
45. Paton NI. Infections in systemic lupus erythematosus patients. Ann Acad Med Singapore 1997;26:694-700.
46. Gladman DD, Hussein F, Ibañez D, Urowitz MB. The nature and outcome of infection in systemic lupus erythematosus. Lupus 2002;11:234-9.
47. Ter Borg EJ, Horst G, Hummel E, Limburg PC, Kallenberg CG. Rises in anti-double stranded DNA antibody levels prior to exacerbations of systemic lupus erythematosus are not merely due to polyclonal B cell activation. Clin Immunol Immunopathol 1991;59:117-28.
48. Reichlin M, Harley VJ. Antinuclear antibodies: an overview. In: Wallace DJ, Hahn BH, eds. Dubois' lupus erythematosus. Philadelphia: Lea & Feiger, 1993:188-94.
49. Van der Veen MJ, Van Der Heide A, Kruize AA, Bijlsma JW. Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate. Ann Rheum Dis 1994;53:224-8.
50. Paton NI, Cheong IK, Kong NC, Segasothy M. Risk factors for infection in Malaysian patients with systemic lupus erythematosus. QJM 1996;89:531-8.
51. Cunhan BA. Infections in nonleukopenic compromised hosts (diabetes mellitus, SLE, steroids, and asplenia) in critical care. Crit Care Clin 1998;14:263-82.
52. Kahlmeter G. The ECO-SENS project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens-interim report. J Antimicrob Chemother 2000;46(suppl S1):15-22.
53. Garau J, Xercavins M, Rodriguez-Carballeira M, Gomez-Vera JR, Coll I, Vidal D, et al. Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrob Agents Chemother 1999;43:2736-41.
54. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999;29:745-58.
55. Stratton MA. Drug-induced systemic lupus erythematosus. Clin Pharm 1985;4:657-63.